These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 38668060
1. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update. Tsukamoto S, Mavrogenis AF, Masunaga T, Honoki K, Fujii H, Kido A, Tanaka Y, Errani C. Curr Oncol; 2024 Apr 08; 31(4):2112-2132. PubMed ID: 38668060 [Abstract] [Full Text] [Related]
2. Current concepts in the treatment of giant cell tumour of bone. van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H. Curr Opin Oncol; 2020 Jul 08; 32(4):332-338. PubMed ID: 32541321 [Abstract] [Full Text] [Related]
4. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence? Scoccianti G, Totti F, Scorianz M, Baldi G, Roselli G, Beltrami G, Franchi A, Capanna R, Campanacci DA. Clin Orthop Relat Res; 2018 Sep 08; 476(9):1783-1790. PubMed ID: 30778015 [Abstract] [Full Text] [Related]
6. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May 08; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
7. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone. Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Orthop Surg; 2019 Dec 08; 11(6):1101-1108. PubMed ID: 31762217 [Abstract] [Full Text] [Related]
11. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone? Hindiskere S, Errani C, Doddarangappa S, Ramaswamy V, Rai M, Chinder PS. Clin Orthop Relat Res; 2020 Nov 08; 478(11):2522-2533. PubMed ID: 32401001 [Abstract] [Full Text] [Related]
12. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum. Bukata SV, Blay JY, Rutkowski P, Skubitz K, Henshaw R, Seeger L, Dai T, Jandial D, Chawla S. Spine (Phila Pa 1976); 2021 Mar 01; 46(5):277-284. PubMed ID: 33038190 [Abstract] [Full Text] [Related]
15. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E. Lancet Oncol; 2019 Dec 01; 20(12):1719-1729. PubMed ID: 31704134 [Abstract] [Full Text] [Related]
16. The role of Denosumab in joint preservation for patients with giant cell tumour of bone. Perrin DL, Visgauss JD, Wilson DA, Griffin AM, Abdul Razak AR, Ferguson PC, Wunder JS. Bone Joint J; 2021 Jan 01; 103-B(1):184-191. PubMed ID: 33380180 [Abstract] [Full Text] [Related]
17. Recurrent giant cell tumour of the distal ulna after en bloc resection with preoperative denosumab use. Fujihara N, Hamada S, Yoshida M, Tsukushi S. BMJ Case Rep; 2021 Nov 11; 14(11):. PubMed ID: 34764115 [Abstract] [Full Text] [Related]
19. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone. Arefpour A, Shafieesabet M, Chehrassan M, Ahmadzadehnanva A, Ghandhari H. Musculoskelet Surg; 2024 Mar 11; 108(1):93-98. PubMed ID: 37940782 [Abstract] [Full Text] [Related]